Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • Blood Cancer Awareness - Exploring Multiple Myeloma and Bone Disease
    Blood Cancer Awareness - Exploring Multiple Myeloma and Bone Disease
    8 September, 2026
    Blood Cancer Awareness - Exploring Multiple Myeloma and Bone Disease Multiple myeloma is a hematological cancer, that disrupts normal hematopoiesis and bone marrow function. It is commonly associate with anemia, renal impairment, hypercalcemia, immunodeficiency, and osteolytic bone lesions. Bone disease is a hallmark of multiple myeloma and results from an imbalance in bone remodeling, with [...]
  • Anti-Oxidized LDL Antibodies and the Gut-Joint Axis
    Anti-Oxidized LDL Antibodies and the Gut-Joint Axis
    1 September, 2026
    Rheumatoid arthritis (RA) is a chronic autoimmune disorder that is characterized by persistent systemic inflammation. The inflammation of the joints over time leads to the destruction of the joint with loss of cartilage and bone erosions (1). Apart of joint damage, RA is increasingly recognized as a disease with wider inflammatory and metabolic implications, including links [...]
  • NT-proANP a biomarker in patients with persistent atrial fibrillation
    NT-proANP a biomarker in patients with persistent atrial fibrillation
    25 August, 2026
    Atrial fibrillation (AF) is the most common sustained arrhythmia, with an estimated 1 in 4 adults expected to develop it during their lifetime. Natriuretic peptide (NP) levels, including NT-proBNP and NT-proANP, are associated with several cardiovascular conditions, including coronary heart disease, heart failure, and hypertension (1, 2). They have also been linked to atrial fibrillation [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events